2023 Next Steps

I find I can't even begin to look at all these threads with depressing titles.

I would like to encourage shareholders to post their thoughts here about where we go next. If you want to rant about how low the price might go, demands to toss the CEO, etc., please save it for those other threads. Otherwise, let's talk about the pipeline and answers we need from the company about the way forward.

Issues like:

Chrohn’s and ulcerative colitis: Why hasn't clinical trials. gov been updated? Is Amy Lightner still the PI? Did they finish recruiting? Will they be reporting results this year?

ARDS: Have we resolved CMC/assay issues to the satisfaction of FDA so we can proceed with that trial when we have funds? Are we talking to partners about potential funding for this trial?

CLBP: Do we have funds and a new potential start date? Are we waiting to find a partner before we start?

CHF meeting: Have we actually requested the meeting that MSB has been forever promising? Is it MSB or FDA that keeps pushing this back?

GVHD: To ask for AA for children, do we need to do another BLA submission or do we plan to ask for this in the type A meeting?

Please folks, let's talk about where we go from here and stop lamenting the past.